Valuation: Septerna, Inc.

Market Cap 158.58Cr 137.85Cr 128.31Cr 117.8Cr 222.46Cr 15TCr 225.91Cr 1.51TCr 593.58Cr 7.54TCr 595.55Cr 582.46Cr 25TCr P/E 2026 *
-20.3x
P/E 2027 * -14.4x
Enterprise Value 123.69Cr 107.52Cr 100.08Cr 92Cr 173.51Cr 12TCr 176.2Cr 1.18TCr 462.98Cr 5.88TCr 464.51Cr 454.31Cr 20TCr EV / Sales 2026 *
16.1x
EV / Sales 2027 * 16.4x
Free-Float
97.17%
Yield 2026 *
-
Yield 2027 * -
1 day-3.60%
1 week+2.57%
Current month+1.37%
1 month-1.91%
3 months+43.80%
6 months+35.64%
Current year+21.77%
1 week 32.84
Extreme 32.845
35.82
1 month 30.55
Extreme 30.55
38.04
Current year 22.78
Extreme 22.78
38.04
1 year 10.62
Extreme 10.6161
38.04
3 years 4.17
Extreme 4.17
38.04
5 years 4.17
Extreme 4.17
38.04
10 years 4.17
Extreme 4.17
38.04
Manager TitleAgeSince
Chief Executive Officer 60 01/11/2021
Director of Finance/CFO 55 06/01/2025
President 58 01/08/2025
Director TitleAgeSince
Director/Board Member 60 01/11/2021
Chairman 50 01/11/2021
Director/Board Member 41 01/11/2021
Date Insider Type Main position Quantity % Market Cap.
15/07/26 Fiscal year

Chairperson

12,000 0.0266%
01/07/26 Fiscal year

Executive/Senior Manager

9,999 0.0222%
29/06/26 Fiscal year

Head of Human Resources

6,534 0.0145%
Change 5-day change 1-year change 3-year change Capi.($)
-3.60%+2.57%+173.57% - 158.58Cr
-1.40%+2.59%-1.71%+11.28% 4.94TCr
-1.59%+12.24%+25.65%+4.36% 3.91TCr
-2.26%-0.89%+403.21%+614.46% 4.09TCr
-2.57%-3.80%+4.11%+46.35% 3.58TCr
-1.74%+8.42%+8.85%+48.87% 3.05TCr
-2.58%-3.68% - - 1.66TCr
-1.12%-5.12%+33.57%+125.38% 1.61TCr
-0.17%-0.37%-2.39%-34.31% 1.28TCr
-0.64%+2.65%+1.25%+8.92% 1.37TCr
Average -1.73%+5.03%+71.79%+103.16% 2.56TCr
Weighted average by Cap. -1.66%+6.66%+77.59%+128.78%

Financials

2026 *2027 *
Net sales 7.69Cr 6.69Cr 6.22Cr 5.71Cr 11Cr 734.22Cr 11Cr 73Cr 29Cr 365.53Cr 29Cr 28Cr 1.23TCr 6.58Cr 5.72Cr 5.33Cr 4.89Cr 9.24Cr 628.45Cr 9.38Cr 63Cr 25Cr 312.87Cr 25Cr 24Cr 1.05TCr
Net income -6.89Cr -5.99Cr -5.57Cr -5.12Cr -9.66Cr -657.3Cr -9.81Cr -66Cr -26Cr -327.23Cr -26Cr -25Cr -1.1TCr -12Cr -11Cr -9.91Cr -9.1Cr -17Cr -1.17TCr -17Cr -116.79Cr -46Cr -581.93Cr -46Cr -45Cr -1.95TCr
Net Debt -35Cr -30Cr -28Cr -26Cr -49Cr -3.33TCr -50Cr -332.77Cr -130.6Cr -1.66TCr -131.03Cr -128.16Cr -5.56TCr -51Cr -44Cr -41Cr -38Cr -71Cr -4.85TCr -72Cr -484.94Cr -190.32Cr -2.42TCr -190.95Cr -186.76Cr -8.1TCr
Logo Septerna, Inc.
Septerna, Inc. is a clinical-stage biotechnology company. The Company is developing G protein-coupled receptor (GPCR) oral small-molecule drug discovery powered by its proprietary Native Complex Platform. Its pipeline of product candidates is focused on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. Its industrial-scale Native Complex Platform is designed to target certain GPCRs for the first time, uncover novel binding pockets for validated receptors, and pursue a wide spectrum of pharmacologies, including agonists, antagonists, and allosteric modulators, to achieve desired therapeutic effects. It is advancing a deep portfolio of oral small molecule GPCR-targeted programs with novel mechanistic approaches to treat diseases across multiple therapeutic areas for patients with unmet needs. It is focused on therapeutic areas, such as neurology, women’s health, cardiovascular, and respiratory disease.
Employees
130
Date Price Change Volume
31/26/31 $33.95 -3.50% 81,889
30/26/30 $35.18 +4.67% 2,66,084
29/26/29 $33.61 -1.06% 1,58,216
28/26/28 $33.97 +1.43% 2,63,368
27/26/27 $33.49 +1.18% 1,43,876
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
35.18USD
Average target price
45.00USD
Spread / Average Target
+27.91%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SEPN Stock